Medtronic reorganizes its restorative therapies segment

Medtronic (NYSE:MDT) is shuffling the deck at its restorative therapies group as it looks to boost its ailing spine and neuromodulation businesses. Fridley, Minn.-based Medtronic said yesterday that restorative therapies sales were up just 1% to $1.88 billion, including a -1% decline for its spine division at $737 million and a -5% slide to $494 million in neuromodulation. Discussing the company’s fiscal 4th-quarter results with analysts yesterday, chairman &CEO Omar Ishrak said a “speed to scale” program in spine helped drive a steady cadence of new product launches, resulting in “a sequential improvement to our growth rate” for the business. In neuromodulation, however, the picture is not as rosy. Drug-pump sales are in a double-digit top-line slide, Ishrak said, as Medtronic copes with an FDA consent decree issued in April 2015 that halted the manufacture of its SynchroMed II pump. Drug pump revenues are expected to be flat from now on, he said. “In [deep-brain stimulation] and pain stim, we are facing increased competition, but as we look ahead we are optimistic,” Ishrak said, according to a Seeking Alpha transcript. “On balance, however, pain stim and DBS could be under some pressure for the next several quarters.” CFO Gary Ellis, in his final earnings call before his retirement this month, noted that the sales decline in neuromodulation wasn’t helped by the loss of $7 mill...
Source: Mass Device - Category: Medical Equipment Authors: Tags: MassDevice Earnings Roundup Neuromodulation/Neurostimulation Spinal Wall Street Beat Medtronic Source Type: news

Related Links:

Publication date: Available online 12 October 2017Source: Progress in Neuro-Psychopharmacology and Biological PsychiatryAuthor(s): Pierre J. Blanchet, Christine Brefel-CourbonAbstractPain is experienced by the vast majority of patients living with Parkinson's disease. It is most often of nociceptive origin, but may also be ascribed to neuropathic (radicular or central) or miscellaneous sources. The recently validated King's Parkinson's Disease Pain Scale is based on 7 domains including musculoskeletal pain, chronic body pain (central or visceral), fluctuation-related pain, nocturnal pain, oro-facial pain, pain with discolo...
Source: Progress in Neuro Psychopharmacology and Biological Psychiatry - Category: Psychiatry Source Type: research
The Neuromodulation market is rapidly growing and has become host to many medtech companies. StimGuard is the latest firm to make significant moves in the space, as it has received CE mark for a wireless neuromodulation device to treat chronic symptoms of overactive bladder. The Pompano Beach, Fla.-based company said its StimGuard would be available in Europe in the summer of 2018. “A wireless system that enables urologists to inject such a clinically proven therapy represents a shift in the field where there has only been one option for over 15 years,” Karl-Dietrich Sievert MD, PhD, professor and co-chairman o...
Source: MDDI - Category: Medical Devices Authors: Tags: Implants Source Type: news
Neuromodulation (NM) is revolutionary technology that acts directly upon nerve system. Deep brain stimulation (DBS) for Parkinson ’s disease and spinal cord stimulation (SCS) for chronic pain are the typical applications of NM.Gait disturbance resulting from Parkinson’s disease or spastic paraparesis become an incapacitating motor symptom, as it significantly affects patients’ quality of life and levels of activity. The optimal DBS stimulus parameter for this symptom has remained unestablished. We experienced some cases ameliorating gait disturbance during subthalamic (STN)–DBS using the lower frequency.
Source: Clinical Neurophysiology - Category: Neuroscience Authors: Source Type: research
Abbott (NYSE:ABT) said today it launched its Proclaim dorsal root ganglion neurostimulator system designed to treat pain in patients with complex regional pain syndrome of the lower limbs. The company’s Proclaim DRG system is designed to be used via Bluetooth with an Apple (NSDQ:AAPL) iPod touch as a system controller and is magnetic resonance-conditional and recharge free, all upgrades from previous versions of the device, the Abbott Park, Ill.-based company said. Abbott said it originally launched the DRG therapy system in 2016 and data from the Accurate study of it showed the system delivers “...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Neuromodulation/Neurostimulation Pain Management Abbott Source Type: news
Publication date: Available online 12 October 2017 Source:Progress in Neuro-Psychopharmacology and Biological Psychiatry Author(s): Pierre J. Blanchet, Christine Brefel-Courbon Pain is experienced by the vast majority of patients living with Parkinson's disease. It is most often of nociceptive origin, but may also be ascribed to neuropathic (radicular or central) or miscellaneous sources. The recently validated King's Parkinson's Disease Pain Scale is based on 7 domains including musculoskeletal pain, chronic body pain (central or visceral), fluctuation-related pain, nocturnal pain, oro-facial pain, pain with discolourati...
Source: Progress in Neuro Psychopharmacology and Biological Psychiatry - Category: Psychiatry Source Type: research
PremiseTrigeminal neuralgia is a severe facial pain disorder that has been studied for decades. Classical trigeminal neuralgia (CTN) is either idiopathic or caused by neurovascular compression. The related painful trigeminal neuropathies are often secondary to other causes, such as multiple sclerosis or trauma. ProblemTherapies for trigeminal neuralgia and neuropathy have often been pharmacologic or surgical. Pharmacologic therapies are not effective in some cases and often cause side effects, some substantial. Surgery can have comorbidity (such as anesthesia dolorosa, or painful differentiation of the affected nerve distr...
Source: Headache: The Journal of Head and Face Pain - Category: Neurology Authors: Tags: Headache Currents Source Type: research
Abstract PREMISE: Trigeminal neuralgia is a severe facial pain disorder that has been studied for decades. Classical trigeminal neuralgia (CTN) is either idiopathic or caused by neurovascular compression. The related painful trigeminal neuropathies are often secondary to other causes, such as multiple sclerosis or trauma. PROBLEM: Therapies for trigeminal neuralgia and neuropathy have often been pharmacologic or surgical. Pharmacologic therapies are not effective in some cases and often cause side effects, some substantial. Surgery can have comorbidity (such as anesthesia dolorosa, or painful differentiation ...
Source: Headache - Category: Neurology Authors: Tags: Headache Source Type: research
In conclusion, documentation is important, a critical part of advocacy and the development process at the larger scale. It isn't just words, but rather a vital structural flow of information from one part of the larger community to another, necessary to sustain progress in any complex field. We would all do well to remember this - and to see that building this documentation is an activity in which we can all pitch in to help. Evidence Suggests that, at Least in Earlier Stages, Alzheimer's Disease Blocks Rather than Destroys Memories https://www.fightaging.org/archives/2017/07/evidence-suggests-that-at-least-in-ea...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
Illustration of a deep brain stimulation lead implanted in the cerebellar dentate nucleus for treatment of post-stroke motor deficits. [Image from Cleveland Clinic]The Cleveland Clinic is pioneering deep brain stimulation for stroke recovery, with an ongoing clinical trial to determine if Boston Scientific’s Vercise DBS system improves movement in recovering stroke patients. Dr. Andre Machado and his team performed the 6-hour deep brain stimulation surgery on Dec. 19, 2016. The procedure implanted electrodes into the cerebellum section of the brain. The deep brain stimulation electrodes emit small electric pulses whi...
Source: Mass Device - Category: Medical Devices Authors: Tags: Biotech Neuromodulation/Neurostimulation Boston Scientific Cleveland Clinic deep brain stimulation MedTech Source Type: news
Last week WIRED Health gathered hundreds of leaders and influencers from across the globe in London to discuss the field of health innovation and technology. In addition to their long lists of honors and historic accolades, the unrivaled lineup ...
Source: Medgadget - Category: Medical Equipment Authors: Tags: Exclusive Source Type: blogs
More News: Back Pain | Baclofen | Brain | Chronic Pain | Deep Brain Stimulation | ENT & OMF | Health | Hospital Management | Hospitals | Medical Devices | Neurology | Neurosurgery | Pain | Profits and Losses